Medrobotics® Announces $25MM Venture Debt Investment Commitment from Western Technology Investment

Medrobotics® Announces $25MM Venture Debt Investment Commitment from Western Technology Investment

6 years ago
Anonymous $roN-uuAfLt

https://www.businesswire.com/news/home/20180613006358/en/

RAYNHAM, Mass.--(BUSINESS WIRE)--Jun 14, 2018--Medrobotics Corp., a medical robotics company, today announced a $25 million venture debt investment commitment from Western Technology Investment (WTI). Medrobotics will use these funds to develop products and applications to allow surgeons to reach anatomy deeper in the digestive tract and to expand its manufacturing capabilities to meet growing demand.

Medrobotics markets the Flex ® Robotic System, the world’s first and only robotic surgical platform which provides Scarfree™ access to hard-to-reach anatomy in otolaryngology and colorectal procedures. Additionally, the Flex ® Robotic System was cleared for robot-assisted visualization in general surgical, gynecological and thoracic procedures in the United States. The Company is also pursuing expanded applications in other areas including transvaginal gynecologic procedures and single port abdominal applications in general surgery, urology and gynecology.

Medrobotics® Announces $25MM Venture Debt Investment Commitment from Western Technology Investment

Jun 14, 2018, 4:13am UTC
https://www.businesswire.com/news/home/20180613006358/en/ > RAYNHAM, Mass.--(BUSINESS WIRE)--Jun 14, 2018--Medrobotics Corp., a medical robotics company, today announced a $25 million venture debt investment commitment from Western Technology Investment (WTI). Medrobotics will use these funds to develop products and applications to allow surgeons to reach anatomy deeper in the digestive tract and to expand its manufacturing capabilities to meet growing demand. > Medrobotics markets the Flex ® Robotic System, the world’s first and only robotic surgical platform which provides Scarfree™ access to hard-to-reach anatomy in otolaryngology and colorectal procedures. Additionally, the Flex ® Robotic System was cleared for robot-assisted visualization in general surgical, gynecological and thoracic procedures in the United States. The Company is also pursuing expanded applications in other areas including transvaginal gynecologic procedures and single port abdominal applications in general surgery, urology and gynecology.